BNET Industries
Market Cap:$6.7K
- Public
- US
Dow Jones Description
Embryo Development Corporation is a Delaware corporation (the "Company" or "Embryo"), which was organized in March 1995 to develop, acquire, manufacture and market various bio- medical devices. The Company has not derived any significant revenues since its inception. The Company was a licensee to seven (7) license agreements (the "License Agreements") and two (2) royalty sharing agreements (the "Royalty Sharing Agreements") with Dr. Lloyd Marks which provided for the exclusive license of seven medical devices and the sharing of royalties of two (2) medical devices, all of which had been developed by Dr. Marks ("Marks Medical Devices"). As of January 2001, all of these licenses had been terminated. The termination of the above license agreements followed a determination by management to conserve capital and that the products licensed could not profitably be developed and commercially marketed by the Company at this time. The Company holds patents to five (5) other medical devices and was the exclusive licensee of one (1) medical device in the areas of emergency medical equipment and peritoneal dialysis warming devices. Although the Company holds the patents and rights to these products, management does not believe that these products have any viable marketability at this time.
Contact Information
305 Madison Avenue, Suite 4510
New York, New York 10165
2128080607
Peer Companies
NAICS Code Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510
News & Analysis
Filter by
embryo development corp. - All News and Analysis
Embryo Development Corp. makes announcement
NEW YORK--BUSINESS WIRE--Feb. 10, 1997--Embryo Development Corp. (NASDAQ:EMBR) announced today that the company through its majority owned subsidiary, Hydrogel Design Systems Inc., has simultaneously entered into and closed on two asset purchase agreements pursuant to which it has acquired substantially all of the assets from two related entities, Novatech Inc....
Additional Resources
Invo Bioscience Plans Presentation at Upcoming Conferences
Wireless News06-12-2009Invo Bioscience Plans Presentation at Upcoming ConferencesType: NewsInvo Bioscience, a medical device company focused on treatment options for patients diagnosed with infertility, announced that management will be presenting at the European Society of Human Reproduction and Embryology annual meeting to be held in Amsterdam, Netherlands on June 28-July 1...
INVO Bioscience, Inc. to Present at Upcoming Industry and Financial Conferences
BEVERLY, Mass. -- INVO Bioscience, Inc. (OTC BB: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, announced today that management will be...
The expression patterns of Cdc25A, Cdc25B, Sox2 and Mnb in central nervous system in early chicken embryos
INTRODUCTION Cell division cycle Cdc genes are required for regulation of cell proliferation. However, others factors are necessary for cell differentiation events. To understand the mechanisms that underlie this regulated process, greater knowledge of the molecular control of the acquisition of cell proliferation and differentiation is required. At...
INVO Bioscience, Inc. Launches INVOcell Procedure in South America in Newly Created INVO Centers and Existing In Vitro Fertilization (IVF) Centers
BEVERLY, Mass. -- INVO Bioscience, Inc. (OTC BB: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, announced today that the first South...
INVO Bioscience Reports Progress with Its INVO Centers in the Middle East and Africa.
Wireless News05-02-2009INVO Bioscience Reports Progress with Its INVO Centers in the Middle East and Africa.Type: NewsINVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, announced that it is making significant progress with its INVO Centers in the Middle East and Africa. The...
INVO Centers in Operation in the Developing Nations Indicate Progress for INVO Bioscience, Inc.
BEVERLY, Mass. -- INVO Bioscience, Inc. (OTC BB: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, announced today that it is making...
US issues rules on embryonic stem cell research
WASHINGTON AFP — The US government Friday unveiled guidelines for publicly-funded embryonic stem cell research limiting it to embryos developed in test tubes for would-be parents but never used. The draft guidelines, issued by the National Institutes of Health, came in response to President Barack Obama's executive order on March...
Stage-specific expression of lanosterol 14[alpha]-demethylase in mouse oocytes in relation to fertilization and embryo development competence
INTRODUCTION To complete successful fertilization and embryo development, the nucleus and cytoplasm maturation of oocyte must be coordinated with intercellular events, including growth, meiotic resumption, and ovulation. Many studies indicated that early embryos produced by in vitro fertilization IVF can not achieve satisfactory implantation and embryo development (Abeydeera...
Differential embryo development among Tibetan Chicken, DRW and Shouguang Chicken exposed to chronic hypoxia
INTRODUCTION Oxygen concentration is essential for embryo development (Jaffee, 1974; Strick et al., 1991; Meuer et al., 1992; Miller et al., 2002; Rouwet et al., 2002; Villamor et al., 2004; Chan and Burggren, 2005). Hypoxia increased embryo mortality (Villamor et al., 2004), induced the retarded growth (Wangensteen et...
- 1
Industry Transcripts by Seeking Alpha
-
Sun Healthcare Group, Inc., Q1 2009 Earnings Call Transcript
on May 27, 2009about SUNH
-
Aflac Incorporated 2009 Financial Analyst Briefing Transcript
on May 20, 2009about AFL
-
Medtronic, Inc. F4Q09 (Qtr End 04/24/09) Earnings Call Transcript
on May 19, 2009about MDT
-
Thoratec Corporation Q1 2009 Earnings Call Transcript
on May 11, 2009about THOR
-
ResMed F3Q09 (Qtr End 3/31/09) Earnings Call Transcript
on May 07, 2009about RMD
IndustryTop Rated
- Lab Techs Are In Short Supply, Despite Recession 18 votes
- On-Call Payments To Physicians Reach Critical Mass 13 votes
- Texas Rescinds Contract With Evercare Medicaid Service 12 votes
- CMS Starts Tightening Screws on Medicare Plans 12 votes
- Healthcare Roundup: MedPac and Hospitals, E-prescribing Savings, IT Worker Shortage, and More 11 votes